subscribeSubscribe
price-trendAsk Us
Journal of Clinical Psychiatry Publishes Data from Alkermes` ALPINE Study

Journal of Clinical Psychiatry Publishes Data from Alkermes` ALPINE Study
PRNEWSWIRE
20 May 2020
Share Share
Alkermes Announces Expansion of Patient Services & Network for ARISTADA®

Alkermes Announces Expansion of Patient Services & Network for ARISTADA®
PR NEWSWIRE
11 May 2020
Share Share
Alkermes says long-acting drugs help schizophrenics stay on medication longer

Alkermes says long-acting drugs help schizophrenics stay on medication longer
Saumya Joseph REUTERS
10 Apr 2019
Share Share
Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics

Longtime Alkermes executive Elliot Ehrich joins Expansion Therapeutics
Amirah Al Idrus FIERCE BIOTECH
13 Nov 2018
Share Share
Alkermes` injectable schizophrenia drug, Aristada Initio gets US FDA approval

Alkermes` injectable schizophrenia drug, Aristada Initio gets US FDA approval
PHARMABIZ
04 Jul 2018
Share Share
FDA Approves ARISTADA INITIO for the Initiation of ARISTADA for Schizophrenia

FDA Approves ARISTADA INITIO for the Initiation of ARISTADA for Schizophrenia
PRESS RELEASE
02 Jul 2018
Share Share
Alkermes to Present Data on Depression and Schizophrenia Portfolios

Alkermes to Present Data on Depression and Schizophrenia Portfolios
PRESS RELEASE
23 May 2018
Share Share
Alkermes’ NDA for Investigational Product Designed for Initiation Onto ARISTADA®

Alkermes’ NDA for Investigational Product Designed for Initiation Onto ARISTADA®
BUSINESSWIRE
16 Nov 2017
Share Share
Alkermes to Initiate New Clinical Study Evaluating ARISTADA® & INVEGA SUSTENNA®

Alkermes to Initiate New Clinical Study Evaluating ARISTADA® & INVEGA SUSTENNA®
BUSINESSWIRE
26 Oct 2017
Share Share
Alkermes Stock Climbs on Positive Test Results for Antidepressant

Alkermes Stock Climbs on Positive Test Results for Antidepressant
Robert Weisman BOSTON GLOBE
21 Oct 2016
Share Share